Edward Carr Biography and Net Worth

Chief Accounting Officer of Dianthus Therapeutics

Mr. Carr is a veteran financial leader with over 30 years of finance and public accounting experience including managing financial operations, financial reporting (including SEC reporting), technical accounting, internal controls, financial planning, treasury, and taxation. Prior to Dianthus, Mr. Carr served as Chief Financial Officer of Abeona Therapeutics, a publicly traded, clinical stage biotechnology company. Prior to Abeona, Mr. Carr served as Assistant Controller at Coty Inc., a multi-billion dollar, publicly traded manufacturing company and as Chief Accounting Officer at Foster Wheeler AG, a multi-billion dollar, publicly traded engineering and construction company. Mr. Carr, who is a Certified Public Accountant, began his career at Ernst & Young LLP. He received his Master of Professional Accountancy and Bachelor of Business Administration from West Virginia University.

What is Edward Carr's net worth?: The estimated net worth of Edward Carr is at least $17.62 million as of April 5th, 2021. Mr. Carr owns 226,291 shares of Dianthus Therapeutics stock worth more than $17,619,017 as of March 16th. This net worth approximation does not reflect any other investments that Mr. Carr may own. Learn More about Edward Carr's net worth.
How old is Edward Carr?: Mr. Carr is currently 55 years old. There are 4 older executives and no younger executives at Dianthus Therapeutics. The oldest executive at Dianthus Therapeutics is Mr. Marino Garcia M.B.A., President, CEO, Secretary & Director, who is 58 years old. Learn More on Edward Carr's age.
How do I contact Edward Carr?: The corporate mailing address for Mr. Carr and other Dianthus Therapeutics executives is 203 Crescent Street, Building 17 Suite 102B, Waltham, MA 02453, United States, . Dianthus Therapeutics can also be reached via phone at 857-242-0170 and via email at [email protected]. Learn More on Edward Carr's contact information.
Has Edward Carr been buying or selling shares of Dianthus Therapeutics?: During the last ninety days, Edward Carr has sold $3,559,646.18 in Dianthus Therapeutics stock. Most recently, Edward Carr sold 43,682 shares of the business's stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $81.49, for a transaction totalling $3,559,646.18. Learn More on Edward Carr's trading history.
Who are Dianthus Therapeutics' active insiders?: Dianthus Therapeutics' insider roster includes Edward Carr (Chief Accounting Officer), Simrat Randhawa (Insider), and Ryan Savitz (CFO). Learn More on Dianthus Therapeutics' active insiders.
Are insiders buying or selling shares of Dianthus Therapeutics?: During the last twelve months, insiders at the sold shares 7 times. They sold a total of 436,968 shares worth more than $25,315,877.41. The most recent insider tranaction occured on March, 12th when CEO Marino Garcia sold 122,918 shares worth more than $10,016,587.82. Insiders at Dianthus Therapeutics own 16.6% of the company. Learn More about insider trades at Dianthus Therapeutics.
Information on this page was last updated on 3/12/2026.

Edward Carr Insider Trading History at Dianthus Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/12/2026	Sell	43,682	$81.49	$3,559,646.18

Edward Carr Buying and Selling Activity at Dianthus Therapeutics

Dianthus Therapeutics Company Overview

Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases. It is developing DNTH103, a monoclonal antibody, which is in Phase 2 clinical trial, for the treatment of generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.

Today's Range

Now: $80.39

$77.82

$81.00

50 Day Range

MA: $52.53

$36.20

$86.92

2 Week Range

Now: $80.39

$13.36

$88.02

Volume

68,976 shs

Average Volume

1,013,138 shs

Market Capitalization

$3.57 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.56

Edward Carr Biography and Net Worth

What is Edward Carr's net worth?

How old is Edward Carr?

How do I contact Edward Carr?

Has Edward Carr been buying or selling shares of Dianthus Therapeutics?

Who are Dianthus Therapeutics' active insiders?

Are insiders buying or selling shares of Dianthus Therapeutics?